Market watch: Upcoming market catalysts in Q4 2018

Nat Rev Drug Discov. 2018 Oct 1;17(10):699. doi: 10.1038/nrd.2018.162.
No abstract available

MeSH terms

  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Depression, Postpartum / drug therapy
  • Drug Approval / methods
  • Drug Industry / methods*
  • Female
  • Globins / therapeutic use
  • Humans
  • Pyrazoles / therapeutic use
  • Pyrimidines / therapeutic use
  • United States
  • United States Food and Drug Administration
  • beta-Thalassemia / drug therapy

Substances

  • Pyrazoles
  • Pyrimidines
  • Globins
  • larotrectinib